hypoxia-activated TLR9 agonist (Convert Pharmaceuticals/University of California)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namehypoxia-activated TLR9 agonist (Convert Pharmaceuticals/University of California)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Francisco
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoConvert Pharmaceuticals SA
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A